Syndrome of Inappropriate Antidiuretic Hormone (SIADH)
Patient presentation
K.G., a 54 year-old male with a pack-a-day, 30-year history of smoking and
small cell lung cancer (staging: extensive) presents to the oncology
outpatient clinic for lab work and physical following chemotherapy two weeks
earlier. Patient presents with 12 lb. weight gain since the week before,
increased weakness/fatigue, and reports muscle cramps with occasional
nausea, vomiting, and diarrhea. Pt is lethargic but AAOx3, with occasional
headaches. No edema noted. Patient’s wife reports patient has “been
urinating less frequently and even accidentally peed the bed once yesterday.
This is so unlike him.” Patient is admitted to oncology unit for a full
work-up.
Differential list
Differential diagnoses include: dehydration, fluid retention, cardiac
disease, hepatic dysfunction, adrenal insufficiency, renal disorders,
thyroid disease, SIADH and/or poorly managed chemotherapy side effects.
Diagnosis
Lab results/Tests: CBC, CMP, plasma osmolality, UA, urine sodium and urine
osmolality, blood cultures. Significant lab results: Serum Na+= 123 mEq/L.
Serum osmolality= 276 mOsm/kg. Urine osmolality= 559 mOsm/kg. Urine sodium=
24 mEq/L. (4 key diagnostic lab values: hyponatremia, decreased serum
osmolality, increased urine osmolality and increased urine sodium).
Electrolytes, BUN, creatinine, albumin and uric acid are also elevated.
Chest X-ray to r/o pulmonary infection. CT scan was later done and revealed
cerebral edema (and ruled out brain tumor/herniation).
Potential causes: There is a fluid imbalance as the ADH
hormone is directing the kidney to conserve water and concentrate urine,
leading to water intoxication and build-up of fluid in the intracellular
space. It was determined that his SCLC tumor (similar to other malignant
neoplasms) is secreting inappropriate and excessive amounts of ADH that
interfere with fluid balance. The patient’s current medications are reviewed
to ensure that SIADH is not medication induced (including opioids,
antidepressants, non-steroidal anti-inflammatory drugs, cytotoxic
chemotherapy). Other nonmalignant causes were ruled out, such as CNS
disorders (infection, hemorrhage, trauma), pulmonary disorders (infection,
TB, abscess) and/or pain, stress, and/or nicotine. After ruling out other
causes, the diagnosis was SIADH secondary to SCLC.
Treatment
For K.G., chemotherapy was given as scheduled in an attempt to eliminate
tumor cells causing the SIADH. Corticosteroids were given to help with
cerebral swelling and decrease neurological implications. A fluid
restriction (800-1,000 ml/day) was implemented and the 4 key lab values were
monitored daily. Lasix® (furosemide) was given to increase urinary water
excretion. If patient is nonresponsive to fluid restriction, and Lasix®,
demeclocycline (a medication that inhibits effect of ADH on renal tubules)
can be given. Although K.G. did not require it, hypertonic 3% saline
infusions, are indicated if hyponatremia becomes life threatening.